Program at a Glance
| 날짜 | 세션 | 시간 | 강의 | 연자 |
|---|---|---|---|---|
| 7/3(금) | Kidney Pancreas Ⅰ |
Update in induction and maintenance immunosuppression | 좌장: 양재석(서울의대), 허규하(연세의대) |
|
| 16:30-16:55 | Indications and optimal dose of ATG and basiliximab | 신성 (울산의대) | ||
| 16:55-17:20 | Optimal target levels of calcineurin inhibitor in various situations | 정병하 (가톨릭의대) | ||
| 17:20-17:45 | Choice and optimal dose of proliferation inhibitors in various situations | 조장희 (경북의대) | ||
| 17:45-18:00 | Q&A | |||
| 7/10(금) | Liver Ⅰ | Current status and future direction of deceased donor liver transplantation in Korea | 좌장: 조재원(성균관의대), 김기훈(울산의대) |
|
| 16:30-16:50 | Current Status of Deceased Donor Liver Graft Recovery and Wait-List Mortality in Korea | 류제호 (부산의대) | ||
| 16:50-17:10 | Liver Allocation and Intervention System in Western countries | 홍근 (이화의대) | ||
| 17:10-17:30 | Current Status and Future Direction of MELD score based liver allocation system in Korea | 김종만 (성균관의대) | ||
| 17:30-17:50 | Various approaches to expand the donor’s pool in Korea | 한영석 (경북의대) | ||
| 17:50-18:00 | Q&A | |||
| 7/17(금) | Basic | Innate immune cells in transplantation | 좌장: 최경호(서울의대), 양재석(서울의대) |
|
| 16:30-16:55 | Current updates on NK cells | 김헌식 (울산의대) | ||
| 16:55-17:20 | Current updates on innate lymphoid cells | 김혜영 (서울의대) | ||
| 17:20-17:45 | Current updates on dendritic cells | 강석조(KAIST) | ||
| 17:45-18:00 | Q&A | |||
| 7/24(금) | Thoracic | Current issues in thoracic transplantation | 좌장: 이진구(연세의대), 이해영(서울의대) |
|
| 16:30-16:45 | When to consider heart-lung transplant | 이상언 (울산의대) | ||
| 16:45-17:00 | LVAD bridge to transplant: optimal timing of heart transplantation | 황호영 (서울의대) | ||
| 17:00-17:15 | Who is an optimal candidate for ECMO bridge to lung transplant? | 김도형 (부산의대) | ||
| 17:15-17:30 | Expanding donor pool for thoracic organs: hepatitis donors | 전경만 (성균관의대) | ||
| 17:30-18:00 | 패널토의 | |||
| 7/31(금) | Kidney /Pancreas Ⅱ |
Update in the management of the metabolic complications in kidney transplantation | 좌장: 이식(전북의대), 박재범(성균관의대) |
|
| 16:30-16:55 | Management and prevention of obesity after kidney transplantation | 김양현 (고려의대) | ||
| 16:55-17:20 | Efficacy and safety of new antidiabetic drugs in kidney transplant recipients | 전재한 (경북의대) | ||
| 17:20-17:45 | Update of post-transplant bone disease: hyperparathyroidism, osteoporosis | 이유미 (연세의대) | ||
| 17:45-18:00 | Q&A | |||
| 8/7(금) | Liver Ⅱ | Fatty liver related problems in liver transplantation | 좌장: 주동진(연세의대), 유희철(전북의대) |
|
| 16:30-16:50 | The risk & selection criteria of fatty liver graft in LDLT and DDLT | 박길춘 (울산의대) | ||
| 16:50-17:10 | Diagnosis and medical treatment of NAFLD and NASH | 전대원 (한양의대) | ||
| 17:10-17:30 | Current status & indication for LT in patients with NASH | 이해원 (서울의대) | ||
| 17:30-17:50 | Management of recurrent or de novo NASH after liver transplantation | 김범경 (연세의대) | ||
| 17:50-18:00 | Q&A | |||
| 8/14(금) | Coordinator | Coordinator session | 좌장: 전경옥(세브란스병원), 손선영(강남세브란스병원) |
|
| 16:30-17:10 | 이식면역 검사와 의미 | 박명희 (KODA) | ||
| 17:10-17:50 | 신장이식에서 본 면역학의 최근 이슈 | 박금보래 (고려의대) | ||
| 17:50-18:00 | Q&A |
